Control and an overall trend of tumor regression were attained over 27 continuous months on everolimus.
← all excerpts
PTEN R130Q Papillary Tumor of the Pineal Region (PTPR) with Chromosome 10 Loss Successfully Treated with Everolimus: A Case Report.
1
—
—